These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32558821)

  • 1. Surveillance of persons-who tested negative for COVID-19 in Ontario, January 22-February 22, 2020.
    Murti M; Whelan M; Saunders A; Hohenadel K; Gubbay J; Buchan S
    Can Commun Dis Rep; 2020 May; 46(5):150-154. PubMed ID: 32558821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First 100 Persons with COVID-19 - Zambia, March 18-April 28, 2020.
    Chipimo PJ; Barradas DT; Kayeyi N; Zulu PM; Muzala K; Mazaba ML; Hamoonga R; Musonda K; Monze M; Kapata N; Sinyange N; Simwaba D; Kapaya F; Mulenga L; Chanda D; Malambo W; Ngosa W; Hines J; Yingst S; Agolory S; Mukonka V
    MMWR Morb Mortal Wkly Rep; 2020 Oct; 69(42):1547-1548. PubMed ID: 33090982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA.
    Ghinai I; McPherson TD; Hunter JC; Kirking HL; Christiansen D; Joshi K; Rubin R; Morales-Estrada S; Black SR; Pacilli M; Fricchione MJ; Chugh RK; Walblay KA; Ahmed NS; Stoecker WC; Hasan NF; Burdsall DP; Reese HE; Wallace M; Wang C; Moeller D; Korpics J; Novosad SA; Benowitz I; Jacobs MW; Dasari VS; Patel MT; Kauerauf J; Charles EM; Ezike NO; Chu V; Midgley CM; Rolfes MA; Gerber SI; Lu X; Lindstrom S; Verani JR; Layden JE;
    Lancet; 2020 Apr; 395(10230):1137-1144. PubMed ID: 32178768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods.
    Marquez C; Kerkhoff AD; Schrom J; Rojas S; Black D; Mitchell A; Wang CY; Pilarowski G; Ribeiro S; Jones D; Payan J; Manganelli S; Rojas S; Lemus J; Jain V; Chamie G; Tulier-Laiwa V; Petersen M; DeRisi J; Havlir DV
    JAMA Netw Open; 2022 Oct; 5(10):e2235844. PubMed ID: 36215069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demographic, clinical, and epidemiologic characteristics of persons under investigation for Coronavirus Disease 2019-United States, January 17-February 29, 2020.
    McGovern OL; Stenger M; Oliver SE; Anderson TC; Isenhour C; Mauldin MR; Williams N; Griggs E; Bogere T; Edens C; Curns AT; Lively JY; Zhou Y; Xu S; Diaz MH; Waller JL; Clarke KR; Evans ME; Hesse EM; Morris SB; McClung RP; Cooley LA; Logan N; Boyd AT; Taylor AW; Bajema KL; Lindstrom S; Elkins CA; Jones C; Hall AJ; Graitcer S; Oster AM; Fry AM; Fischer M; Conklin L; Gokhale RH
    PLoS One; 2021; 16(4):e0249901. PubMed ID: 33857209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series.
    Böhmer MM; Buchholz U; Corman VM; Hoch M; Katz K; Marosevic DV; Böhm S; Woudenberg T; Ackermann N; Konrad R; Eberle U; Treis B; Dangel A; Bengs K; Fingerle V; Berger A; Hörmansdorfer S; Ippisch S; Wicklein B; Grahl A; Pörtner K; Muller N; Zeitlmann N; Boender TS; Cai W; Reich A; An der Heiden M; Rexroth U; Hamouda O; Schneider J; Veith T; Mühlemann B; Wölfel R; Antwerpen M; Walter M; Protzer U; Liebl B; Haas W; Sing A; Drosten C; Zapf A
    Lancet Infect Dis; 2020 Aug; 20(8):920-928. PubMed ID: 32422201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application.
    Lauer SA; Grantz KH; Bi Q; Jones FK; Zheng Q; Meredith HR; Azman AS; Reich NG; Lessler J
    Ann Intern Med; 2020 May; 172(9):577-582. PubMed ID: 32150748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.
    Poletti P; Tirani M; Cereda D; Trentini F; Guzzetta G; Sabatino G; Marziano V; Castrofino A; Grosso F; Del Castillo G; Piccarreta R; Andreassi A; Melegaro A; Gramegna M; Ajelli M; Merler S;
    JAMA Netw Open; 2021 Mar; 4(3):e211085. PubMed ID: 33688964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Presentation of Coronavirus Disease 2019 (COVID-19) in Pregnant and Recently Pregnant People.
    Afshar Y; Gaw SL; Flaherman VJ; Chambers BD; Krakow D; Berghella V; Shamshirsaz AA; Boatin AA; Aldrovandi G; Greiner A; Riley L; Boscardin WJ; Jamieson DJ; Jacoby VL;
    Obstet Gynecol; 2020 Dec; 136(6):1117-1125. PubMed ID: 33027186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.
    Guo YR; Cao QD; Hong ZS; Tan YY; Chen SD; Jin HJ; Tan KS; Wang DY; Yan Y
    Mil Med Res; 2020 Mar; 7(1):11. PubMed ID: 32169119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid Sentinel Surveillance for COVID-19 - Santa Clara County, California, March 2020.
    Zwald ML; Lin W; Sondermeyer Cooksey GL; Weiss C; Suarez A; Fischer M; Bonin BJ; Jain S; Langley GE; Park BJ; Moulia D; Benedict R; Nguyen N; Han GS
    MMWR Morb Mortal Wkly Rep; 2020 Apr; 69(14):419-421. PubMed ID: 32271724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical-Epidemiological Characteristics of the First Patients Diagnosed with COVID-19 in Cuba.
    Molina-Águila N; Cruz-Rodríguez E; Ferrán-Torres RM; Galindo-Santana BM; López-Almaguer Y; Romero-Placeres M
    MEDICC Rev; 2021 Apr; 23(2):15. PubMed ID: 33974611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed Recognition of Coronavirus Disease 2019 (COVID-19) in New York City: A Descriptive Analysis of COVID-19 Illness Prior to 29 February 2020.
    Keating P; Sell J; Chen J; Ackelsberg J; Wu W; Tsoi B; Weiss D
    Clin Infect Dis; 2023 Feb; 76(3):e250-e254. PubMed ID: 35723267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Spectrum of COVID-19 Cases and their Correlation with S.LDH Levels- An Observational Study from Southeast Rajasthan.
    Gupta D; Sharma R; Patwardhan B; Mathur RD
    J Assoc Physicians India; 2021 Sep; 69(9):11-12. PubMed ID: 34585882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
    Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
    Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study.
    Nakakubo S; Kishida N; Okuda K; Kamada K; Iwama M; Suzuki M; Yokota I; Ito YM; Nasuhara Y; Boucher RC; Konno S
    Lancet Infect Dis; 2023 Nov; 23(11):1244-1256. PubMed ID: 37399831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.